PillRx only · Tablet · Oral
Telmisartan And Amlodipine
Amlodipine Besylate + Telmisartan
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US10 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$2.988
Latest avg · Jul 22, 2026
+0%
Since Dec 17, 2025
3
Active US suppliers
100%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
1.2K
Rx · 2026 Q1
57K
Units dispensed
+20%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Mylan Pharmaceuticals Inc. | unknown | 4 | SUPPLYING |
| Alembic Pharmaceuticals Limited | unknown | 4 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | unknown | 0 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Apr 1, 2019RECALLRecall (Class III): Telmisartan and Amlodipine Tablets 80 mg/5 mg, 30 tablet bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc.…
Failed Impurities/Degradation Specifications; 18 month long term stability study. — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed to 6 wholesalers/ drug chains and 2 mail order pharmacies that may have further distribute the …